-
Posted by
Two Blokes Apr 26 -
Filed in
Stock
-
2 views
Astellas Pharma Inc. (OTCPK:ALPMF) Q4 2024 Earnings Conference Call April 25, 2025 4:00 AM ET Company Participants Hiromitsu Ikeda - Chief Communications and IR Officer Naoki Okamura - Representative Director, President & Chief Executive Officer Claus Zieler - Chief Commercial Officer & Medical Affairs Officer Tadaaki Taniguchi - Chief Medical Officer Atsushi Kitamura - Chief Financial Officer Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Seiji Wakao - JPMorgan Securities Akinori Ueda - Goldman Sachs Securities Shinichiro Muraoka - Morgan Stanley MUFG Securities Hiroyuki Matsubara - Nomura Securities Miki Sogi - Sanford C. Bernstein Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - UBS Securities Hiromitsu Ikeda Thank you very much for joining our FY 2024 Financial Results Announcement Meeting by Astellas Pharma Inc. out of your very busy schedule today.
